nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—KCNH6—telencephalon—malignant glioma	0.0199	0.102	CbGeAlD
Terazosin—Speech disorder—Carmustine—malignant glioma	0.0167	0.0234	CcSEcCtD
Terazosin—Speech disorder—Temozolomide—malignant glioma	0.0161	0.0226	CcSEcCtD
Terazosin—KCNH7—central nervous system—malignant glioma	0.0158	0.0813	CbGeAlD
Terazosin—KCNH7—cerebellum—malignant glioma	0.0155	0.0795	CbGeAlD
Terazosin—Coordination abnormal—Carmustine—malignant glioma	0.0146	0.0205	CcSEcCtD
Terazosin—Neck pain—Carmustine—malignant glioma	0.0145	0.0204	CcSEcCtD
Terazosin—Coordination abnormal—Temozolomide—malignant glioma	0.0141	0.0198	CcSEcCtD
Terazosin—Musculoskeletal pain—Temozolomide—malignant glioma	0.014	0.0197	CcSEcCtD
Terazosin—Urinary incontinence—Carmustine—malignant glioma	0.0139	0.0195	CcSEcCtD
Terazosin—Urinary incontinence—Temozolomide—malignant glioma	0.0134	0.0188	CcSEcCtD
Terazosin—KCNH7—brain—malignant glioma	0.0126	0.0646	CbGeAlD
Terazosin—Abnormal vision—Carmustine—malignant glioma	0.0125	0.0176	CcSEcCtD
Terazosin—Abnormal vision—Temozolomide—malignant glioma	0.0121	0.017	CcSEcCtD
Terazosin—KCNH6—central nervous system—malignant glioma	0.0113	0.058	CbGeAlD
Terazosin—Nasal congestion—Temozolomide—malignant glioma	0.0111	0.0155	CcSEcCtD
Terazosin—ADRA1D—telencephalon—malignant glioma	0.011	0.0565	CbGeAlD
Terazosin—Face oedema—Carmustine—malignant glioma	0.0101	0.0141	CcSEcCtD
Terazosin—Face oedema—Temozolomide—malignant glioma	0.00973	0.0137	CcSEcCtD
Terazosin—Hypokalaemia—Carmustine—malignant glioma	0.00949	0.0133	CcSEcCtD
Terazosin—Hypokalaemia—Temozolomide—malignant glioma	0.00917	0.0129	CcSEcCtD
Terazosin—KCNH6—brain—malignant glioma	0.00896	0.046	CbGeAlD
Terazosin—Bronchitis—Temozolomide—malignant glioma	0.00837	0.0118	CcSEcCtD
Terazosin—Dysuria—Temozolomide—malignant glioma	0.00814	0.0114	CcSEcCtD
Terazosin—Pollakiuria—Temozolomide—malignant glioma	0.00804	0.0113	CcSEcCtD
Terazosin—Erectile dysfunction—Temozolomide—malignant glioma	0.00802	0.0113	CcSEcCtD
Terazosin—Depression—Carmustine—malignant glioma	0.00801	0.0112	CcSEcCtD
Terazosin—Photosensitivity reaction—Temozolomide—malignant glioma	0.00795	0.0112	CcSEcCtD
Terazosin—Weight increased—Temozolomide—malignant glioma	0.00792	0.0111	CcSEcCtD
Terazosin—Urinary tract infection—Carmustine—malignant glioma	0.00781	0.011	CcSEcCtD
Terazosin—Depression—Temozolomide—malignant glioma	0.00774	0.0109	CcSEcCtD
Terazosin—Urinary tract infection—Temozolomide—malignant glioma	0.00755	0.0106	CcSEcCtD
Terazosin—Sinusitis—Temozolomide—malignant glioma	0.00728	0.0102	CcSEcCtD
Terazosin—ADRA1A—brainstem—malignant glioma	0.00712	0.0366	CbGeAlD
Terazosin—Oedema peripheral—Carmustine—malignant glioma	0.0071	0.00997	CcSEcCtD
Terazosin—Visual impairment—Carmustine—malignant glioma	0.00695	0.00976	CcSEcCtD
Terazosin—Pharyngitis—Temozolomide—malignant glioma	0.00692	0.00971	CcSEcCtD
Terazosin—Oedema peripheral—Temozolomide—malignant glioma	0.00687	0.00964	CcSEcCtD
Terazosin—Eye disorder—Carmustine—malignant glioma	0.00674	0.00946	CcSEcCtD
Terazosin—Visual impairment—Temozolomide—malignant glioma	0.00672	0.00943	CcSEcCtD
Terazosin—Eye disorder—Temozolomide—malignant glioma	0.00651	0.00914	CcSEcCtD
Terazosin—Tinnitus—Temozolomide—malignant glioma	0.0065	0.00912	CcSEcCtD
Terazosin—Arrhythmia—Carmustine—malignant glioma	0.00644	0.00904	CcSEcCtD
Terazosin—ADRA1B—central nervous system—malignant glioma	0.00639	0.0328	CbGeAlD
Terazosin—ADRA1A—telencephalon—malignant glioma	0.00632	0.0324	CbGeAlD
Terazosin—Malnutrition—Carmustine—malignant glioma	0.00628	0.00881	CcSEcCtD
Terazosin—ADRA1D—central nervous system—malignant glioma	0.00625	0.0321	CbGeAlD
Terazosin—KCNH2—telencephalon—malignant glioma	0.0061	0.0313	CbGeAlD
Terazosin—Back pain—Carmustine—malignant glioma	0.00607	0.00852	CcSEcCtD
Terazosin—Malnutrition—Temozolomide—malignant glioma	0.00607	0.00852	CcSEcCtD
Terazosin—Dysgeusia—Temozolomide—malignant glioma	0.00594	0.00834	CcSEcCtD
Terazosin—Vision blurred—Carmustine—malignant glioma	0.00592	0.00831	CcSEcCtD
Terazosin—Tremor—Carmustine—malignant glioma	0.00588	0.00826	CcSEcCtD
Terazosin—Back pain—Temozolomide—malignant glioma	0.00587	0.00824	CcSEcCtD
Terazosin—Vision blurred—Temozolomide—malignant glioma	0.00572	0.00803	CcSEcCtD
Terazosin—Tremor—Temozolomide—malignant glioma	0.00568	0.00798	CcSEcCtD
Terazosin—Ill-defined disorder—Temozolomide—malignant glioma	0.00563	0.0079	CcSEcCtD
Terazosin—Angioedema—Temozolomide—malignant glioma	0.00554	0.00778	CcSEcCtD
Terazosin—ABCB1—blood vessel—malignant glioma	0.00552	0.0283	CbGeAlD
Terazosin—Malaise—Temozolomide—malignant glioma	0.00547	0.00768	CcSEcCtD
Terazosin—Vertigo—Temozolomide—malignant glioma	0.00545	0.00765	CcSEcCtD
Terazosin—Convulsion—Carmustine—malignant glioma	0.00544	0.00764	CcSEcCtD
Terazosin—Palpitations—Temozolomide—malignant glioma	0.00536	0.00753	CcSEcCtD
Terazosin—Myalgia—Carmustine—malignant glioma	0.00535	0.0075	CcSEcCtD
Terazosin—Chest pain—Carmustine—malignant glioma	0.00535	0.0075	CcSEcCtD
Terazosin—Anxiety—Carmustine—malignant glioma	0.00533	0.00748	CcSEcCtD
Terazosin—Cough—Temozolomide—malignant glioma	0.00529	0.00743	CcSEcCtD
Terazosin—Convulsion—Temozolomide—malignant glioma	0.00526	0.00738	CcSEcCtD
Terazosin—Confusional state—Carmustine—malignant glioma	0.00517	0.00725	CcSEcCtD
Terazosin—Arthralgia—Temozolomide—malignant glioma	0.00517	0.00725	CcSEcCtD
Terazosin—Myalgia—Temozolomide—malignant glioma	0.00517	0.00725	CcSEcCtD
Terazosin—Anxiety—Temozolomide—malignant glioma	0.00515	0.00723	CcSEcCtD
Terazosin—Oedema—Carmustine—malignant glioma	0.00512	0.00719	CcSEcCtD
Terazosin—Discomfort—Temozolomide—malignant glioma	0.0051	0.00716	CcSEcCtD
Terazosin—ADRA1B—brain—malignant glioma	0.00508	0.0261	CbGeAlD
Terazosin—Dry mouth—Temozolomide—malignant glioma	0.00505	0.00709	CcSEcCtD
Terazosin—Thrombocytopenia—Carmustine—malignant glioma	0.00502	0.00704	CcSEcCtD
Terazosin—Tachycardia—Carmustine—malignant glioma	0.005	0.00702	CcSEcCtD
Terazosin—Confusional state—Temozolomide—malignant glioma	0.00499	0.00701	CcSEcCtD
Terazosin—ADRA1D—brain—malignant glioma	0.00496	0.0255	CbGeAlD
Terazosin—Anaphylactic shock—Temozolomide—malignant glioma	0.00495	0.00695	CcSEcCtD
Terazosin—Oedema—Temozolomide—malignant glioma	0.00495	0.00695	CcSEcCtD
Terazosin—Anorexia—Carmustine—malignant glioma	0.00488	0.00686	CcSEcCtD
Terazosin—Thrombocytopenia—Temozolomide—malignant glioma	0.00485	0.00681	CcSEcCtD
Terazosin—KCNH2—medulla oblongata—malignant glioma	0.0048	0.0246	CbGeAlD
Terazosin—Hypotension—Carmustine—malignant glioma	0.00479	0.00672	CcSEcCtD
Terazosin—Hyperhidrosis—Temozolomide—malignant glioma	0.00479	0.00672	CcSEcCtD
Terazosin—Anorexia—Temozolomide—malignant glioma	0.00472	0.00663	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00467	0.00655	CcSEcCtD
Terazosin—Insomnia—Carmustine—malignant glioma	0.00463	0.0065	CcSEcCtD
Terazosin—Paraesthesia—Carmustine—malignant glioma	0.0046	0.00646	CcSEcCtD
Terazosin—Dyspnoea—Carmustine—malignant glioma	0.00457	0.00641	CcSEcCtD
Terazosin—Somnolence—Carmustine—malignant glioma	0.00456	0.00639	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00451	0.00633	CcSEcCtD
Terazosin—Insomnia—Temozolomide—malignant glioma	0.00448	0.00629	CcSEcCtD
Terazosin—Decreased appetite—Carmustine—malignant glioma	0.00445	0.00625	CcSEcCtD
Terazosin—Paraesthesia—Temozolomide—malignant glioma	0.00445	0.00624	CcSEcCtD
Terazosin—Dyspnoea—Temozolomide—malignant glioma	0.00441	0.0062	CcSEcCtD
Terazosin—Somnolence—Temozolomide—malignant glioma	0.0044	0.00618	CcSEcCtD
Terazosin—KCNH2—midbrain—malignant glioma	0.00438	0.0225	CbGeAlD
Terazosin—Pain—Carmustine—malignant glioma	0.00438	0.00615	CcSEcCtD
Terazosin—Constipation—Carmustine—malignant glioma	0.00438	0.00615	CcSEcCtD
Terazosin—Dyspepsia—Temozolomide—malignant glioma	0.00436	0.00612	CcSEcCtD
Terazosin—Decreased appetite—Temozolomide—malignant glioma	0.0043	0.00604	CcSEcCtD
Terazosin—KCNH2—spinal cord—malignant glioma	0.00428	0.022	CbGeAlD
Terazosin—Fatigue—Temozolomide—malignant glioma	0.00427	0.00599	CcSEcCtD
Terazosin—Pain—Temozolomide—malignant glioma	0.00423	0.00594	CcSEcCtD
Terazosin—Constipation—Temozolomide—malignant glioma	0.00423	0.00594	CcSEcCtD
Terazosin—Feeling abnormal—Carmustine—malignant glioma	0.00422	0.00593	CcSEcCtD
Terazosin—Gastrointestinal pain—Carmustine—malignant glioma	0.00419	0.00588	CcSEcCtD
Terazosin—Feeling abnormal—Temozolomide—malignant glioma	0.00408	0.00573	CcSEcCtD
Terazosin—Abdominal pain—Carmustine—malignant glioma	0.00405	0.00569	CcSEcCtD
Terazosin—Body temperature increased—Carmustine—malignant glioma	0.00405	0.00569	CcSEcCtD
Terazosin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00405	0.00568	CcSEcCtD
Terazosin—Abdominal pain—Temozolomide—malignant glioma	0.00391	0.00549	CcSEcCtD
Terazosin—Body temperature increased—Temozolomide—malignant glioma	0.00391	0.00549	CcSEcCtD
Terazosin—Hypersensitivity—Carmustine—malignant glioma	0.00378	0.0053	CcSEcCtD
Terazosin—Asthenia—Carmustine—malignant glioma	0.00368	0.00516	CcSEcCtD
Terazosin—Hypersensitivity—Temozolomide—malignant glioma	0.00365	0.00512	CcSEcCtD
Terazosin—ADRA1A—central nervous system—malignant glioma	0.00359	0.0184	CbGeAlD
Terazosin—Asthenia—Temozolomide—malignant glioma	0.00355	0.00499	CcSEcCtD
Terazosin—ADRA1A—cerebellum—malignant glioma	0.00351	0.018	CbGeAlD
Terazosin—Diarrhoea—Carmustine—malignant glioma	0.00351	0.00492	CcSEcCtD
Terazosin—Pruritus—Temozolomide—malignant glioma	0.0035	0.00492	CcSEcCtD
Terazosin—KCNH2—central nervous system—malignant glioma	0.00347	0.0178	CbGeAlD
Terazosin—KCNH2—cerebellum—malignant glioma	0.00339	0.0174	CbGeAlD
Terazosin—Dizziness—Carmustine—malignant glioma	0.00339	0.00476	CcSEcCtD
Terazosin—Diarrhoea—Temozolomide—malignant glioma	0.00339	0.00476	CcSEcCtD
Terazosin—ABCB1—embryo—malignant glioma	0.00329	0.0169	CbGeAlD
Terazosin—Dizziness—Temozolomide—malignant glioma	0.00327	0.0046	CcSEcCtD
Terazosin—Vomiting—Carmustine—malignant glioma	0.00326	0.00457	CcSEcCtD
Terazosin—Rash—Carmustine—malignant glioma	0.00323	0.00453	CcSEcCtD
Terazosin—Dermatitis—Carmustine—malignant glioma	0.00323	0.00453	CcSEcCtD
Terazosin—Headache—Carmustine—malignant glioma	0.00321	0.00451	CcSEcCtD
Terazosin—Vomiting—Temozolomide—malignant glioma	0.00315	0.00442	CcSEcCtD
Terazosin—Rash—Temozolomide—malignant glioma	0.00312	0.00438	CcSEcCtD
Terazosin—Dermatitis—Temozolomide—malignant glioma	0.00312	0.00438	CcSEcCtD
Terazosin—Headache—Temozolomide—malignant glioma	0.0031	0.00435	CcSEcCtD
Terazosin—Nausea—Carmustine—malignant glioma	0.00304	0.00427	CcSEcCtD
Terazosin—Nausea—Temozolomide—malignant glioma	0.00294	0.00413	CcSEcCtD
Terazosin—ABCB1—retina—malignant glioma	0.00291	0.0149	CbGeAlD
Terazosin—ADRA1A—brain—malignant glioma	0.00285	0.0146	CbGeAlD
Terazosin—KCNH2—brain—malignant glioma	0.00275	0.0141	CbGeAlD
Terazosin—ABCB1—telencephalon—malignant glioma	0.00268	0.0137	CbGeAlD
Terazosin—ABCB1—medulla oblongata—malignant glioma	0.0021	0.0108	CbGeAlD
Terazosin—ABCB1—midbrain—malignant glioma	0.00192	0.00987	CbGeAlD
Terazosin—ABCB1—spinal cord—malignant glioma	0.00188	0.00963	CbGeAlD
Terazosin—ABCB1—central nervous system—malignant glioma	0.00152	0.00781	CbGeAlD
Terazosin—ABCB1—cerebellum—malignant glioma	0.00149	0.00764	CbGeAlD
Terazosin—ABCB1—brain—malignant glioma	0.00121	0.0062	CbGeAlD
Terazosin—ADRA1A—Signaling Pathways—JAG2—malignant glioma	5.68e-05	0.000612	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP2B6—malignant glioma	5.67e-05	0.000611	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—AKT2—malignant glioma	5.66e-05	0.00061	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CG—malignant glioma	5.62e-05	0.000606	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	5.56e-05	0.0006	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PTPN11—malignant glioma	5.52e-05	0.000595	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOTCH2—malignant glioma	5.48e-05	0.000591	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	5.44e-05	0.000587	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PIK3CD—malignant glioma	5.44e-05	0.000586	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—H3F3A—malignant glioma	5.41e-05	0.000583	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—F2—malignant glioma	5.37e-05	0.000578	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KNG1—malignant glioma	5.37e-05	0.000578	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCR3—malignant glioma	5.35e-05	0.000577	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—YWHAE—malignant glioma	5.21e-05	0.000561	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NTRK2—malignant glioma	5.21e-05	0.000561	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—IDH1—malignant glioma	5.19e-05	0.000559	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FLT1—malignant glioma	5.19e-05	0.000559	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	5.18e-05	0.000559	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—DUSP6—malignant glioma	5.16e-05	0.000556	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AKT2—malignant glioma	5.14e-05	0.000554	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	5.14e-05	0.000554	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CG—malignant glioma	5.14e-05	0.000554	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NTRK1—malignant glioma	5.12e-05	0.000551	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—JAG1—malignant glioma	5.1e-05	0.000549	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOTCH3—malignant glioma	5.08e-05	0.000547	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SPHK1—malignant glioma	5.02e-05	0.000541	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FBXW7—malignant glioma	4.99e-05	0.000538	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CD—malignant glioma	4.94e-05	0.000532	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP2C18—malignant glioma	4.92e-05	0.00053	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—BDKRB2—malignant glioma	4.9e-05	0.000528	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—F2—malignant glioma	4.87e-05	0.000525	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—H3F3A—malignant glioma	4.8e-05	0.000517	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—F2—malignant glioma	4.77e-05	0.000514	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MMP3—malignant glioma	4.76e-05	0.000512	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCR3—malignant glioma	4.76e-05	0.000512	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PIK3CB—malignant glioma	4.74e-05	0.000511	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	4.72e-05	0.000509	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CDKN2B—malignant glioma	4.71e-05	0.000508	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AKT2—malignant glioma	4.7e-05	0.000506	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CG—malignant glioma	4.66e-05	0.000503	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—YWHAE—malignant glioma	4.63e-05	0.000499	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NTRK2—malignant glioma	4.63e-05	0.000499	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FLT1—malignant glioma	4.61e-05	0.000496	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—DUSP6—malignant glioma	4.59e-05	0.000494	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PTPN11—malignant glioma	4.58e-05	0.000494	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTK2—malignant glioma	4.58e-05	0.000493	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	4.57e-05	0.000492	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CG—malignant glioma	4.56e-05	0.000492	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CXCL8—malignant glioma	4.56e-05	0.000491	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOTCH2—malignant glioma	4.55e-05	0.000491	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—JAG1—malignant glioma	4.53e-05	0.000488	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CD—malignant glioma	4.52e-05	0.000487	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOTCH3—malignant glioma	4.51e-05	0.000486	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HES1—malignant glioma	4.5e-05	0.000485	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NCOR1—malignant glioma	4.47e-05	0.000482	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KNG1—malignant glioma	4.46e-05	0.00048	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FBXW7—malignant glioma	4.44e-05	0.000478	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—RAF1—malignant glioma	4.41e-05	0.000475	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—IL2—malignant glioma	4.36e-05	0.000469	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—BDKRB2—malignant glioma	4.35e-05	0.000469	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—F2—malignant glioma	4.33e-05	0.000467	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CB—malignant glioma	4.31e-05	0.000464	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PDGFRA—malignant glioma	4.28e-05	0.000461	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AKT2—malignant glioma	4.27e-05	0.00046	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NTRK1—malignant glioma	4.25e-05	0.000458	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AKT2—malignant glioma	4.17e-05	0.00045	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SPP1—malignant glioma	4.16e-05	0.000448	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CG—malignant glioma	4.14e-05	0.000447	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CXCL8—malignant glioma	4.14e-05	0.000446	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CD—malignant glioma	4.1e-05	0.000442	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PTPN11—malignant glioma	4.07e-05	0.000439	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOTCH2—malignant glioma	4.04e-05	0.000436	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CD—malignant glioma	4.01e-05	0.000432	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTT1—malignant glioma	3.98e-05	0.000429	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KNG1—malignant glioma	3.96e-05	0.000426	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL2—malignant glioma	3.96e-05	0.000426	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP3—malignant glioma	3.95e-05	0.000425	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TERT—malignant glioma	3.94e-05	0.000425	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CB—malignant glioma	3.94e-05	0.000424	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CDKN2B—malignant glioma	3.91e-05	0.000422	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.86e-05	0.000416	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PDGFB—malignant glioma	3.85e-05	0.000414	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FGFR1—malignant glioma	3.83e-05	0.000412	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTK2—malignant glioma	3.8e-05	0.000409	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AKT2—malignant glioma	3.79e-05	0.000409	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCL8—malignant glioma	3.78e-05	0.000408	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NTRK1—malignant glioma	3.77e-05	0.000406	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HIF1A—malignant glioma	3.77e-05	0.000406	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HES1—malignant glioma	3.73e-05	0.000402	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS1—malignant glioma	3.73e-05	0.000402	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NCOR1—malignant glioma	3.71e-05	0.0004	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—RAF1—malignant glioma	3.66e-05	0.000395	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CAV1—malignant glioma	3.64e-05	0.000393	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CD—malignant glioma	3.64e-05	0.000393	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—IL2—malignant glioma	3.61e-05	0.00039	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KDR—malignant glioma	3.6e-05	0.000388	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CB—malignant glioma	3.57e-05	0.000385	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PDGFRA—malignant glioma	3.55e-05	0.000383	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP3—malignant glioma	3.51e-05	0.000378	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CB—malignant glioma	3.5e-05	0.000377	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CDKN2B—malignant glioma	3.48e-05	0.000375	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FN1—malignant glioma	3.47e-05	0.000374	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—F2—malignant glioma	3.47e-05	0.000374	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—BCHE—malignant glioma	3.46e-05	0.000373	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SPP1—malignant glioma	3.45e-05	0.000372	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCL8—malignant glioma	3.43e-05	0.00037	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—BAD—malignant glioma	3.43e-05	0.000369	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SLC5A5—malignant glioma	3.42e-05	0.000369	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOTCH1—malignant glioma	3.4e-05	0.000366	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTK2—malignant glioma	3.37e-05	0.000364	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCL8—malignant glioma	3.36e-05	0.000362	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CD80—malignant glioma	3.33e-05	0.000358	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APC—malignant glioma	3.32e-05	0.000358	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CG—malignant glioma	3.32e-05	0.000358	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HES1—malignant glioma	3.32e-05	0.000357	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NCOR1—malignant glioma	3.3e-05	0.000355	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL2—malignant glioma	3.28e-05	0.000354	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EGF—malignant glioma	3.28e-05	0.000354	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TERT—malignant glioma	3.27e-05	0.000352	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTPN11—malignant glioma	3.26e-05	0.000352	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—RAF1—malignant glioma	3.25e-05	0.00035	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—IL2—malignant glioma	3.21e-05	0.000346	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PDGFB—malignant glioma	3.19e-05	0.000344	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FGFR1—malignant glioma	3.18e-05	0.000342	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CB—malignant glioma	3.17e-05	0.000342	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PDGFRA—malignant glioma	3.16e-05	0.00034	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.15e-05	0.00034	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HIF1A—malignant glioma	3.13e-05	0.000337	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—BRAF—malignant glioma	3.12e-05	0.000336	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SPP1—malignant glioma	3.06e-05	0.00033	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCL8—malignant glioma	3.05e-05	0.000329	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKT2—malignant glioma	3.04e-05	0.000327	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CAV1—malignant glioma	3.03e-05	0.000326	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—EGFR—malignant glioma	3.02e-05	0.000326	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KDR—malignant glioma	2.99e-05	0.000322	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CD—malignant glioma	2.92e-05	0.000315	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL2—malignant glioma	2.92e-05	0.000314	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TERT—malignant glioma	2.91e-05	0.000313	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PIK3CA—malignant glioma	2.89e-05	0.000312	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—F2—malignant glioma	2.88e-05	0.00031	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FN1—malignant glioma	2.88e-05	0.00031	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—KRAS—malignant glioma	2.86e-05	0.000308	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—BAD—malignant glioma	2.85e-05	0.000307	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PDGFB—malignant glioma	2.84e-05	0.000306	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FGFR1—malignant glioma	2.82e-05	0.000304	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOTCH1—malignant glioma	2.82e-05	0.000304	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FGF2—malignant glioma	2.79e-05	0.000301	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HIF1A—malignant glioma	2.78e-05	0.000299	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CD80—malignant glioma	2.76e-05	0.000297	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTP1—malignant glioma	2.76e-05	0.000297	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CG—malignant glioma	2.76e-05	0.000297	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APC—malignant glioma	2.76e-05	0.000297	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EGF—malignant glioma	2.72e-05	0.000294	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTPN11—malignant glioma	2.71e-05	0.000292	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CAV1—malignant glioma	2.69e-05	0.00029	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CAT—malignant glioma	2.68e-05	0.000289	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KDR—malignant glioma	2.66e-05	0.000286	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CA—malignant glioma	2.63e-05	0.000283	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MDM2—malignant glioma	2.61e-05	0.000282	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RAF1—malignant glioma	2.61e-05	0.000281	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—BRAF—malignant glioma	2.59e-05	0.000279	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ERBB2—malignant glioma	2.58e-05	0.000278	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—F2—malignant glioma	2.56e-05	0.000276	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FN1—malignant glioma	2.56e-05	0.000276	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CB—malignant glioma	2.54e-05	0.000274	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NCOR1—malignant glioma	2.53e-05	0.000273	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—BAD—malignant glioma	2.53e-05	0.000272	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKT2—malignant glioma	2.52e-05	0.000272	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—EGFR—malignant glioma	2.51e-05	0.000271	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	2.5e-05	0.00027	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CD80—malignant glioma	2.45e-05	0.000264	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APC—malignant glioma	2.45e-05	0.000264	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	2.45e-05	0.000264	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCL8—malignant glioma	2.44e-05	0.000263	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CD—malignant glioma	2.42e-05	0.000261	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EGF—malignant glioma	2.42e-05	0.000261	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	2.4e-05	0.000259	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CA—malignant glioma	2.4e-05	0.000259	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—KRAS—malignant glioma	2.37e-05	0.000256	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—AKT1—malignant glioma	2.36e-05	0.000255	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CASP3—malignant glioma	2.34e-05	0.000252	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL2—malignant glioma	2.34e-05	0.000252	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FGF2—malignant glioma	2.32e-05	0.00025	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—BRAF—malignant glioma	2.3e-05	0.000248	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKT2—malignant glioma	2.24e-05	0.000241	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	2.23e-05	0.00024	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MMP9—malignant glioma	2.21e-05	0.000238	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTEN—malignant glioma	2.2e-05	0.000237	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CA—malignant glioma	2.18e-05	0.000235	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MDM2—malignant glioma	2.17e-05	0.000234	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RAF1—malignant glioma	2.16e-05	0.000233	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	2.15e-05	0.000232	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AKT1—malignant glioma	2.14e-05	0.000231	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	2.14e-05	0.000231	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	2.13e-05	0.00023	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	2.11e-05	0.000228	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	2.11e-05	0.000227	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CAV1—malignant glioma	2.06e-05	0.000223	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FGF2—malignant glioma	2.06e-05	0.000222	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	2.03e-05	0.000219	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—VEGFA—malignant glioma	1.99e-05	0.000214	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—STAT3—malignant glioma	1.97e-05	0.000212	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	1.96e-05	0.000211	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CASP3—malignant glioma	1.94e-05	0.000209	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL2—malignant glioma	1.94e-05	0.000209	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	1.94e-05	0.000209	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MDM2—malignant glioma	1.93e-05	0.000208	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RAF1—malignant glioma	1.92e-05	0.000207	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	1.9e-05	0.000205	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CG—malignant glioma	1.88e-05	0.000203	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	1.88e-05	0.000202	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP9—malignant glioma	1.84e-05	0.000198	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MYC—malignant glioma	1.83e-05	0.000197	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTEN—malignant glioma	1.82e-05	0.000197	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARG—malignant glioma	1.82e-05	0.000196	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	1.8e-05	0.000194	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EGFR—malignant glioma	1.79e-05	0.000193	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	1.78e-05	0.000192	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	1.74e-05	0.000188	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CASP3—malignant glioma	1.73e-05	0.000186	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL2—malignant glioma	1.72e-05	0.000186	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KRAS—malignant glioma	1.69e-05	0.000182	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CD—malignant glioma	1.65e-05	0.000178	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	1.65e-05	0.000178	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—STAT3—malignant glioma	1.63e-05	0.000176	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP9—malignant glioma	1.63e-05	0.000176	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTEN—malignant glioma	1.62e-05	0.000175	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	1.58e-05	0.00017	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	1.55e-05	0.000167	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MYC—malignant glioma	1.52e-05	0.000163	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TP53—malignant glioma	1.5e-05	0.000162	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EGFR—malignant glioma	1.48e-05	0.00016	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	1.46e-05	0.000158	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—STAT3—malignant glioma	1.45e-05	0.000156	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CB—malignant glioma	1.44e-05	0.000155	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS2—malignant glioma	1.43e-05	0.000154	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KRAS—malignant glioma	1.4e-05	0.000151	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MYC—malignant glioma	1.35e-05	0.000145	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EGFR—malignant glioma	1.32e-05	0.000142	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	1.29e-05	0.000139	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKT1—malignant glioma	1.27e-05	0.000137	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTEN—malignant glioma	1.25e-05	0.000134	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TP53—malignant glioma	1.25e-05	0.000134	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KRAS—malignant glioma	1.24e-05	0.000134	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	1.14e-05	0.000123	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TP53—malignant glioma	1.11e-05	0.000119	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKT1—malignant glioma	1.05e-05	0.000113	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKT1—malignant glioma	9.34e-06	0.000101	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CA—malignant glioma	8.79e-06	9.47e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKT1—malignant glioma	7.18e-06	7.73e-05	CbGpPWpGaD
